Outcome-based payment could be future of CRO industry; AstraZeneca signs on with web-based outsourcing service;

 @DamianFierce: Covance took a $12.7M loss in the second quarter, but analysts are still optimistic about the company's future. More | Follow @DamianFierce

> Outcome-based payment for CROs may be the future of the industry, according to one strategic outsourcing firm. News

> AstraZeneca ($AZN) has signed on to use Assay Depot, an Internet database that unites pharmas and contractors. Article

> Cleveland's ImageIQ has secured a contract with Histogenics to provide imaging analytics for a Phase II trial of the company's NeoCart implant. More

> Clinical trials conducted by drugmakers may be biased, a federal group says, as companies sometimes deliberately compare new treatments to inferior drugs. Story

> GVK Biosciences has cleared an FDA audit of its Ahmedabad Clinical Pharmacology Unit, a 110-bed facility in India. Release

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.

PRA Health has hired a former FDA clinical research lead to help run its decentralized study unit.